MYECO GROUP LTD — Capital/Financing Update 2019

May 16, 2019

==> picture [109 x 44] intentionally omitted <==

ASX RELEASE

17 May 2019

ISSUE OF PLACEMENT SHARES AND OPIONS - SECTION 708A(5)(e) NOTICE

SECOS Group Limited (“SECOS” or “the Company”) has issued 31,785,750 fully paid ordinary shares ( Shares ) at issue price of $0.04 (4 cents) per share together with 15,892,875 unlisted options to acquire fully paid ordinary shares ( Options ) with an exercise price of $0.06 (6 cents) expiring on 16 May 2021. Shares and Options were issued to sophisticated investors under the placement announced to the market on 2 May 2019 ( Placement ) pursuant to the Company’s placement capacity under Listing Rule 7.1.

Directors of SECOS have applied for 8,071,500 shares and 4,035,750 unlisted options on the same terms as the Placement. The issue of Shares and Options to Directors is subject to shareholder approval in next Annual General Meeting.

The Placement raised $1,594,290 further strengthening the Company’s ability to execute its business plan in a growth market the Company is experiencing.

In respect of the issue of shares, the Company gives notice under section 708A (5)(e) of the Corporations Act that:

The abovementioned shares were issued without disclosure to investors under Part 6D.2 of the Corporations Act.

The Company also states, that as at the date of this notice:

• it has complied with the provisions of Chapter 2M Corporations Act as they apply to the Company; and section 674 Corporations Act; and

• it is not aware of any excluded information within the meaning of Sections 708A(7) and 708A(8) of the Corporations Act.

An Appendix 3B applying for quotation of the new shares is attached.

Edmond Tern Company Secretary +61 433369997

etern@secosgroup.com.au

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Name of entity

SECOS Group Limited

ABN

89 064 755 237

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1 +Class of+securities issued or to be issued 2 Number of+securities issued or to be issued (if known) or maximum number which may be issued 3 Principal terms of the+securities (e.g. if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)	Fully paid ordinary shares.
	31,785,750Ordinary Shares
	Fully paid ordinary shares ranking equally with ordinary shares from date of allotment.

Do the[+] securities rank equally in all respects from the[+] issue date with an existing[+] class of quoted[+] securities? If the additional[+] securities do not rank equally, please state:

• the date from which they do • Fully paid ordinary shares ranking equally with

• 4 the extent to which they participate for the next ordinary shares from date of allotment. dividend, (in the case of a trust, distribution) or interest payment

• the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

5 Issue price or consideration Issue price of $0.04/share . 31,785,750 shares issued pursuant to the placement to professional and sophisticated Purpose of the issue investors, announced to the market on 2 May (If issued as consideration for 6 2019. the acquisition of assets, clearly identify those assets)

Proceed to be used for working capital to fund the growth of biodegradable resin market.

Is the entity an[+] eligible entity that has obtained security holder approval under rule 7.1A? 6a Yes. If Yes, complete sections 6b – 6h in relation to the[+] securities the subject of this Appendix 3B , and comply with section 6i The date the security holder 6b resolution under rule 7.1A was 30 November 2018 passed Number of[+] securities issued 6c without security holder approval NIL under rule 7.1 Number of[+] securities issued 6d with security holder approval NIL under rule 7.1A

• See chapter 19 for defined terms.

04/03/2013

Appendix 3B Page 1

6e Number of+securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting) 6f Number of+securities issued under an exception in rule 7.2 6g If+securities issued under rule 7.1A, was issue price at least 75% of 15-day VWAP as calculated under rule 7.1A.3? Include the+issue date and both values. Include the source of the VWAP calculation. 6h If+securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements 6i Calculate the entity’s remaining issue capacity under rule 7.1 and rule 7.1A – complete Annexure 1 and release to ASX Market Announcements 7 +Issue dates Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A. Cross reference: item 33 of Appendix 3B. 8 Number and +class of all +securities quoted on ASX (_including_the +securities in section 2 if applicable)	NIL
	NIL
	N/A
	N/A.
	Refer to Annexure 1
	16 May 2019
	Number	+Class
	335,443,077	Fully paid ordinary shares

• See chapter 19 for defined terms.

Appendix 3B Page 2

04/03/2013

9 Number and +class of all +securities not quoted on ASX (_including_the +securities in section 2 if applicable) 10 Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)	Number	+Class
	950,000	SES89445 Convertible Notes 30112020
	783,783	SES89429 Convertible Notes 01072021
	15,892,875	Options 17052021
	No plans to pay dividends at this stage.

Part 2 - Pro rata issue – Not applicable

11 Is security holder approval required? 12 Is the issue renounceable or non- renounceable? 13 Ratio in which the+securities will be offered 14 +Class of+securities to which the offer relates 15 +Record date to determine entitlements 16 Will holdings on different registers (or sub registers) be aggregated for calculating entitlements? 17 Policy for deciding entitlements in relation to fractions 18 Names of countries in which the entity has security holders who will not be sent new offer documents Note: Security holders must be told how their entitlements are to be dealt with. Cross reference: rule 7.7. 19 Closing date for receipt of acceptances or renunciations	n/a

• See chapter 19 for defined terms.

04/03/2013

Appendix 3B Page 3

20 Names of any underwriters Amount of any underwriting fee 21 or commission Names of any brokers to the 22 issue Fee or commission payable to 23 the broker to the issue Amount of any handling fee payable to brokers who lodge 24 acceptances or renunciations on behalf of security holders If the issue is contingent on 25 security holders’ approval, the date of the meeting Date entitlement and acceptance 26 form and offer documents will be sent to persons entitled If the entity has issued options, and the terms entitle option holders to participate on 27 exercise, the date on which notices will be sent to option holders Date rights trading will begin (if 28 applicable) Date rights trading will end (if 29 applicable) How do security holders sell their 30 entitlements in full through a broker? How do security holders sell part of their entitlements through a 31 broker and accept for the balance?

• See chapter 19 for defined terms.

Appendix 3B Page 4

04/03/2013

• 32 How do security holders dispose of their entitlements (except by sale through a broker)?

• 33 + Issue date

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

• 34 Type of[+] securities ( tick one )

• (a) + Securities described in Part 1

• (b)[All other ][+][securities ]

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

• 35 If the[+] securities are[+] equity securities, the names of the 20 largest holders of the additional[+] securities, and the number and percentage of additional + securities held by those holders

36 If the[+] securities are[+] equity securities, a distribution schedule of the additional + securities setting out the number of holders in the categories 1 - 1,000

1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over

37 A copy of any trust deed for the additional[+] securities

• See chapter 19 for defined terms.

04/03/2013

Appendix 3B Page 5

Entities that have ticked box 34(b)

• Number of[+] securities for which

• 38 + quotation is sought + Class of + securities for which

• 39 quotation is sought

Do the[+] securities rank equally in all respects from the[+] issue date with an existing[+] class of quoted + securities?

If the additional[+] securities do not rank equally, please state:

• the date from which they do

• 40 • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

• the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

Reason for request for quotation now Example: In the case of restricted securities, end of restriction period 41 (if issued upon conversion of another[+] security, clearly identify that other[+] security)

Number + Class Number and + class of all + securities quoted on ASX 42 ( including the[+] securities in clause 38)

• See chapter 19 for defined terms.

Appendix 3B Page 6

04/03/2013

Quotation agreement

• 1 + Quotation of our additional + securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.

• 2 We warrant the following to ASX.

• The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.

• There is no reason why those[+] securities should not be granted[+] quotation.

• An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

• Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no-one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.

• If we are a trust, we warrant that no person has the right to return the + securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.

• 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

• 4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before[+] quotation of the + securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Sign here: [sent electronically without signature] Print name: Edmond Tern, Company Secretary

Date : 17 May 2019

• See chapter 19 for defined terms.

04/03/2013

Appendix 3B Page 7

Appendix 3B – Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities

Introduced 01/08/12 Amended 04/03/13

Part 1

Rule 7.1 – Issues exceeding 15% of capital

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

art 1	art 1
Rule 7.1 – Issues exceeding 15% of capital
Step 1: Calculate “A”, the base figure from which the placement capacity is calculated
Insertnumber of fully paid+ordinary securities on issue 12 months before the +issue date or date of agreement to issue	212,026,620
Addthe following:
• Number of fully paid +ordinary securities issued in that 12 month period under an exception in rule 7.2	91,630,707
• Number of partly paid +ordinary securities that became fully paid in that 12 month period
• Number of fully paid +ordinary securities issued in that 12 month period with shareholder approval	91,630,707
Note: • Include only ordinary securities here – other classes of equity securities cannot be added • Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annex It may be useful to set out issues of securities on different dates as separate line items
Subtractthe number of fully paid +ordinary securities cancelled during that 12 month period	-
“A”	335,443,077

• See chapter 19 for defined terms.

Appendix 3B Page 8

04/03/2013

Step 2: Calculate 15% of “A”

Step 2: Calculate 15% of “A”	Step 2: Calculate 15% of “A”
“B”	0.15 [Note: this value cannot be changed]
Multiply“A” by 0.15	50,316,462
Step 3: Calculate “C”, the amount of placement capacity under rule 7.1 that has already been used
Insertnumber of+equity securities issued or agreed to be issued in that 12 month period_not counting_those issued:
Under an exception in rule 7.2	-
Under rule 7.1A
With security holder approval under rule 7.1 or rule 7.4
Note: • This applies to equity securities, unless specifically excluded – not just ordinary securities • Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed • It may be useful to set out issues of securities on different dates as separate line items
“C”	47,678,625
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining placement capacity under rule 7.1
“A” x 0.15 Note: number must be same as shown in Step 2	50,316,462
Subtract“C” Note: number must be same as shown in Step 3	47,678,625
Total[“A” x 0.15] – “C”	2,637,837 [Note: this is the remaining placement capacity under rule 7.1]

• See chapter 19 for defined terms.

04/03/2013

Appendix 3B Page 9

Part 2

Rule 7.1A – Additional placement capacity for eligible entities

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

art 2	art 2
Rule 7.1A – Additional placement capacity for eligible entities
Step 1: Calculate “A”, the base figure from which the placement capacity is calculated
“A” Note: number must be same as shown in Step 1 of Part 1	335,443,077
Step 2: Calculate 10% of “A”
“D”	0.10 Note: this value cannot be changed
Multiply“A” by 0.10	33,544,308
Step 3: Calculate “E”, the amount of placement capacity under rule 7.1A that has already been used
Insertnumber of+equity securities issued or agreed to be issued in that 12 month period under rule 7.1A Notes: • This applies to equity securities – not just ordinary securities • Include here – if applicable – the securities the subject of the Appendix 3B to which this form is annexed • Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained • It may be useful to set out issues of securities on different dates as separate line items	NIL
“E”	NIL
Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A
“A” x 0.10 Note: number must be same as shown in Step 2	33,544,308
Subtract “E” Note: number must be same as shown in Step 3	NIL
Total[“A” x 0.10] – “E”	33,544,308 Note: this is the remaining placement capacity under rule 7.1A

• See chapter 19 for defined terms.

Appendix 3B Page 10

04/03/2013